The vaccine, which is based on the ChAd3 simian adenoviral platform, achieved promising results in a Phase I clinical trial.
Many bioprocessors seek high-throughput systems for development, and this approach based on yeast surface display provides ...
Making complex proteins and unique biological entities is getting increasingly complex. A generalized CHO host may not be the ...
Archon Biosciences emerges from stealth to advance a new class of biologic invented in Nobel Prize-winning computational ...
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany (Merck KGaA), invested $76 million to expand its antibody drug conjugate (ADC) manufacturing capabilities ...
Developers can use insights from this research to inform buffer selection and experimental design, even without building a separate model.
Genomics' launched two new products while Bruker rolled out new technology for its CellScape™ Precise Spatial Proteomics platform.
In this GEN webinar, Konlin Shen, PhD, will discuss practical applications of enzymatic DNA synthesis technology in DNA nanotechnology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback